BROOKE BECKWITH: Open Payments
NPI 1598288615 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,587 in 89 payments from 29 companies in 2025. Trend: 2023 $2,200 · 2024 $4,659 · 2025 $2,587
Food & beverage: $2,024Consulting: $540Education: $23
| Company | Payments | Amount |
|---|---|---|
| Nuvation Bio Inc. | 1 | $540 |
| AstraZeneca Pharmaceuticals LP | 20 | $516 |
| Janssen Biotech, Inc. | 8 | $173 |
| Gilead Sciences, Inc. | 7 | $156 |
| Novartis Pharmaceuticals Corporation | 6 | $145 |
| Daiichi Sankyo Inc. | 5 | $116 |
| PharmaEssentia USA Corporation | 3 | $100 |
| Merck Sharp & Dohme LLC | 4 | $92 |
| SOBI, INC | 4 | $80 |
| E.R. Squibb & Sons, L.L.C. | 4 | $74 |
Products named: IBTROZI, IMFINZI, Trodelvy, ENHERTU, KISQALI, BESREMI, KEYTRUDA, RYBREVANT.
Industry payments across TX — which companies pay providers there.
